Atlas Trials

Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia

Clinical trial NCT00021749 · COMPLETED

Trial details

NCT number
NCT00021749
Sponsor
Genta Incorporated
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Chronic Lymphocytic LeukemiaCLL
Start date
2001-01-01
Primary completion
2003-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.